APPLICATIONS PUBLISHED 6 APRIL 2005

Controlled-release pharmaceutical formulations
Pfizer Products 1519713*

Method and apparatus for producing liposomes
Protiva Biotherapeutics 1519714*

Nanoparticulate fibrate formulations
Elan Pharma International; Fournier Laboratories Ireland 1519715*

Extended-release tablets comprising divalproex sodium
Sherman, Bernard Charles 1519716*

Controlled release compns
Temrel 1519717*

At least partially degradable films containing an active ingredient and method for the production thereof
AgfaPhoto 1519718*

Methods for the treatment of sinusitis
Novartis 1519719*

Novel formate salt of O-desmethylvenlaflaxine
Wyeth 1519720*

Polymer affinity matrix, a method for the production and use thereof
Gambro Lundia 1519721*

Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents
Pharmacia & Upjohn 1519722*

Novel glucagon antagonists/inverse agonists
Novo Nordisk 1519723*

Frederiamycin derivatives as medicaments for treating tumours
Biofrontera Pharmaceuticals Holding 1519724*

Methods for targeting quadruplex DNA
Cyternex 1519725*

Utilisation of heteroarene carboxamide as dopamine-D3 ligands for the treatment of CNS diseases
Schwarz Pharma 1519726*

4-(4-methylpiperazin-1-ylmethyl)-4-methyl-3-(4-pyridin-3-yl)pyrimidine-2-ylamino)phenyl-benzamide for treating pulmonary fibrosis
The Administrators of the Tulane Educational Fund 1519727*

4-(2-fluorophenyl_6-methyl-2(1-piperazinyl)thieno(2,3-D) pyrimidine in the treatment of functional bowel disorder
Arachnova Therapeutics 1519728*

Pyrrolotriazinone compounds and their use to treat diseases
Bristol-Myers Squibb 1519729*

Novel use of imidazotriazinones
Bayer HealthCare 1519730*

Combination of azelastine and steroids
Cipla 1519731*

Use of vasopeptidase inhibitors in the treatment of nephropathy
Aventis Pharma Deutschland 1519732*

Compsns for cancer therapy comprising saponins or sapogenins
Panagin Pharmaceuticals 1519733*

Ciclesonide-containing sterile aqueous suspension
ALTANA Pharma 1519734*

Assays and implements for determining and modulating HSP90 binding activity
Conforma Therapeutic Corp 1519735*

Use of HEC1 antagonists in the treatment of proliferative disorders and cancer
Max-Planck-Gesellschaft fuer Foerderung der Wissenschaften 1519736*

Fibrin nanoparticles and uses thereof
Hapto Biotech 1519737*

Herbal compsn for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases
Chula, Murali Krishna 1519738*

Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body
Al Azazi, Shifa Abdo Saeed Ahmed 1519739*

Rapid improvement of cognition in conditions related to A-beta
Eli Lilly 1519740*

Proteins associated with cells growth, differentiation and death
Incyte Genomics 1519741*

Osteoclast-associated receptor
The Rockefeller University 1519742*

Use of an interleukin 1 receptor antagonist and/or pyrrp;idinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
University of Zurich 1519743*

Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
Wyeth 1519744*

Method to enhance an immune response of nucleic acid vaccination
Lipoxen Technologies 1519745*

Use of digoxin immune FAB for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients
Adair, Charles David 1519746*

Human monoclonal antibodies to prostate specific membrane antigen (PSMA)
Mederax 1519747*

Microparticle with CD28-specific monoclonal antibodies
TeGenero 1519748*

Chemotactic factor inhibitor for modulating inflammatory reactions
Universite Lavel; Ryckman, Carle; Vandal, Karen; Rouleau, Pascal 1519749*

Oxygenating agents for enhancing host responses to microbial infections
Exponential Biotherapies 1519750*

Compsns comprising panethetine for the treatment of dyslipidaemia
Esperion Therapeutics 1519751*

Use of CETP inhibitors and antihypertensive agents as well as optionally HMG CoA reductase inhibitors
Pfizer Products 1519752*

Pharmaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor
BMRA Corp 1519753*

Use of CETP inhibitors and optionally HMG CoA reductase inhibitors and/or antihypertensive agents
Pfizer Products 1519754*

Stinging cell expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compsns and devices utilising such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
Nanocyte 1519755*

Use of metal complexes containing perfluoroalkyl as contrast agents in magnetic resonance imaging for representing intravascular thrombi
Schering 1519756*

Scanning suspension comprising a particle with a diameter of at least 1 micrometre
Universitair Medisch Centrum Utrecht 1519757*

Compsn based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
Genfit 1519908*

Polyene carboxylic acid derivatives, method for their production and the use thereof
Aventis Pharma Deutschland 1519909*

Chiral dopant with phenylethanediol functionality
Koninkiljke Philips Electronics 1519910*

Nitrophenol preparation method
Rhodia Chimie 1519911*

Process for increasing the selectivity of the hydrogenation of 4,4"-diamonodiphenylmethane to 4,4"-diaminodicyclohexylmethane in the presence of an N-alkyl-4,4"-diaminodiphenylmethane
Degussa 1519912*

Phenyl benzamides
Bayer CropScience 1519913*

Novel alkaline earth metal complexes and use thereof
Solvay Barium Strontium 1519914*

Tricyclic steroid hormone nuclear receptor modulators
Eli Lilly 1519915*

Heat sensitive recording material
Ciba Specialty Chemicals Holding 1519916*

Carbon-11 and fluorine-18 labelled radioligands for positron emission tomography (PET) imaging for the brain serotonin transporters
The Trustees of Columbia University in the City of New York 1519917*

Peptide inhibitors of SMAC protein binding to inhibitor of apoptosis proteins (IAP)
Novartis 1519918*

Indolin phenylsulphonamide derivatives
Bayer HealthCare 1519919*

Novel tetrahydropyridine derivatives as renon inhibitors
Actelion Pharmaceuticals 1519920*

Substituted anthranilic amide derivatives and methods of use
Amgen 1519921*

Di-aryl-substituted ethane pyridone PDE4 inhibitors
Merck Frosst Canada 1519922*

Novel benzimidazol-2-one derivatives and their use
Poseidon Pharmaceuticals 1519923*

Difluorothioacetamides of oxazolidinones as antibacterial agents
Pharmacia & Upjohn 1519924*

Oxazole derivatives and their use as insulin sensitisers
F Hoffmann-La Roche 1519925*

Method for producing 3,4-dichloron-(2-cyano-phenyl)-5-isothiazole carboxamide
Bayer CropScience 1519926*

Method for producing 3,4-dichloron-(2-cyano-phenyl)-5-isothiazole carboxamide
Bayer CropScience 1519927*

Method for producing heterocyclic fluoroalkenyl sulphones
Bayer CropScience 1519928*

2,1,3-benzothiadiazoles for use as electronic active components
Covion Organic Semiconductors 1519929*

Benzoprostacyclin intermediates and methods for their preparation
Johnson Matthey 1519930*

Chiral 3,4-dihydro-2H-pyran compounds
BASF 1519931*

Bisarylsulphonamide compounds and their use in cancer therapy
Cyclacel 1519932*

Quinuclidine amide derivatives
Almirall Prodesfarma 1519933*

Pyrazoloisoquinoline derivatives for inhibiting NSF(k)B-inducing kinase (NIK)
Aventis Pharma Deutschland 1519934*